FDA Inspection 1041525 - Gemini Pharmaceuticals, Inc. - February 16, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Gemini Pharmaceuticals, Inc., with an inspection on February 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Gemini Pharmaceuticals, Inc.
Inspection Date: February 16, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 5f815dde-5720-44ae-a6e5-ab350f64a85e

Violation Codes4

21 CFR 211.122(a)21 CFR 211.42(c)21 CFR 211.5821 CFR 211.80(a)

Full citation text and observation details available on the Dashboard.